S5-21.6 - From the Vault: Comments on the 2023 AASLD Revised Practice Guidance Looking back 17 months to the publication of revised AASLD Practice Guidance. surfingmash.com/s5-21-6-from-t… #MASH #MASLD #AASLD #PracticeGuidance #NASHpodcast #SurfingNASH #FattyLiver

S5-E13.6 - 𝗢𝗻𝗲 𝗬𝗲𝗮𝗿 𝗔𝗴𝗼: When Global Fatty Live Day Was #NASHDay 2023 This conversation looks back to highlights of SurfingMASH's coverage of GLI's 2023 event, International NASHDAY. surfingmash.com/s5-e13-6-one-y… #NASHDAY2023 #GlobalFattyLiverDay #NASHpodcast #SurfingNASH

S5-E11.6 – From the Vault: Another Strategic Role for Prescribing MASH Drugs This 2023 conversation raises the question of prescribing MASH drugs adjunctive to other therapies, most notably HCC. surfingmash.com/s5-e11-6-from-… #MASH #HCC #NASHpodcast #SurfingNASH #FattyLiver

hubs.la/Q02dT-C40 #GlobalFattyLiverDiseaseDay #MASLD #NASHpodcast #SurfingNASH #FattyLiver Echosens, Global Liver Institute Madrigal Pharmaceuticals Novo Nordisk

hubs.la/Q02dT1Dw0 Patient advocates Neeraj Mistry of the Fatty Liver Foundation and Jenn Leigh Jones of@SoberLivers join to discuss the merging of their organizations and the impact of the new nomenclature on how patients might look at their disease. #MASLD #SurfingNASH #FattyLiver

hubs.la/Q02dQNlf0 #MASLD #MASH #Karolinska Institute #CarePathways #NASHpodcast #SurfingNASH #FattyLiver Echosens, Madrigal Pharmaceuticals Novo Nordisk

hubs.la/Q02dH16B0 Hepatology researcher and Key Opinion Leader Naim Alkhouri joins us to discuss… #MASLD #MASH #DrugDevelopment #CarePathways #NASHpodcast #SurfingNASH #FattyLiver @89bio Echosens, Madrigal Pharmaceuticals Novo Nordisk Siemens Healthineers Geneva Fittje

hubs.la/Q02dy0Px0 Surfing the MASH Tsunami kicks off its 2023 wrap-up conversations with Jeff Lazarus, 2023 winner of the Distinguished Scientific Achievement Award from the American Liver Foundation National #NewNomenclature #ResearchinAction #MASLD #NASHpodcast #SurfingNASH #FattyLiver

Get Ready for our upcoming Year In Review interviews! A lot to cover for this year… make Sure your Podcast App is subscribed to make Sure you don't miss any of these conversations. #surfingNASH #FattyLiverDisease #Podcast #YearInReview

We just received our 2023 year-end numbers from Spotify. They're pretty dazzling, and we wanted to share them with our LinkedIn followers first! In 2023, Spotify listenership increased by 50%… #surfingNASH #surfingMASH #fattyliverpodcast #NAFLD

We are proud to partner with the FattyLiverAlliance as educational partner for the Second Annual Primary Care NAFLD and NASH Summit. #fattyliverdisease #education #surfingNASH #NASH

hubs.la/Q02bWB8F0 TLM2022, NITs, AASLD #NASHpodcast #SurfingNASH #FattyLiver

hubs.la/Q02bWh9V0 This conversation covers a pivotal session on the new MASLD nomenclature, plus the developing class of triple agonists. #TLM2023 #AASLD #Nomenclature #TripleAgonists #Stigma #NASHpodcast #SurfingNASH #FattyLiver Boehringer Ingelheim Madrigal Pharmaceuticals

hubs.ly/Q02bWnp80 This conversation covers what the panelists found exciting, liver science, VCTE, regulatory approvals using NITs or AI and other issues at TLM 2023. #TLM2023 #VCTE #SinglecellOmics #NASHpodcast #SurfingNASH #FattyLiver Echosens Madrigal Pharmaceuticals

hubs.la/Q02bVZN70 This conversation covers what the panelists found exciting, important or striking about the presentations covering NITs, AI and bariatric surgery at TLM2023. #TLM2023 #NITs #AI #BariatricSurgery #NASHpodcast #SurfingNASH #FattyLiver Madrigal Pharmaceuticals

hubs.la/Q02bW2S60 This conversation covers what the panelists found exciting, important or striking about the presentations of clinical trial results at TLM 2023. TLM2023, AASLD, resmetirom, PPARs, rare liver disease #NASHpodcast #SurfingNASH #FattyLiver Madrigal Pharmaceuticals

hubs.la/Q02bWbqk0 This conversation between Scott Friedman, Laurent Castera, Louise Campbell and Roger Green covers the four panelists’ general impressions of TLM2023, both the good and bad of it. #TLM2023 #AASLD #NASHpodcast #SurfingNASH #FattyLiver Madrigal Pharmaceuticals

hubs.la/Q02bHB6X0 Profs. Laurent Castera and Scott Friedman join Louise Campbell and Roger Green to discuss highlights of the recent TLM2023 conference. # TLM2023, MASLD/NAFLD, LiverDisease, RareLiverDisease #NASHpodcast #SurfingNASH #FattyLiver Madrigal Pharmaceuticals